Ducol FY26: Bitumag-led scale-up and a broader chemicals push

Ducol Organics And Colours Limited closed FY26 with a sharp step-up in scale at the consolidated level, reflecting the integration of Bitumag Industries and a broader push beyond pigment dispersions. Consolidated revenue from operations rose to INR 136.07 crore in FY26, while profit after tax increased to INR 7.25 crore. The company also reported stronger profitability in the second half, with consolidated H2 FY26 revenue at INR 71.55 crore and EBITDA of INR 8.79 crore.

The story, however, is not uniformly smooth across reported lines. Management noted that profitability at the PAT level was affected by one-time acquisition-related expenses and finance costs linked to acquisition funding. This is visible in the standalone numbers, where FY26 revenue growth came with a decline in standalone PAT, which management attributed primarily to acquisition-led borrowings and due diligence expenses.

Financial performance: scale up, margin stability, and acquisition costs

The main feature of FY26 is the widening gap between consolidated performance and standalone profitability. Consolidated numbers include Bitumag operations, which lifted overall revenue. At the same time, financing costs related to the acquisition affected profits, particularly on the standalone side.

In H2 FY26, consolidated revenue from operations was INR 71.55 crore, compared to standalone revenue of INR 42.78 crore. Consolidated EBITDA for H2 FY26 was INR 8.79 crore with a margin of 12.29 percent. Standalone EBITDA in H2 FY26 was INR 6.08 crore with a higher margin of 14.22 percent. The presentation explicitly notes that additional finance cost of INR 1.17 crore in H2 FY26 was incurred due to acquisition-related borrowings and that margins are expected to improve as the debt is repaid.

For the full year, consolidated revenue from operations was INR 136.07 crore, consolidated EBITDA was INR 14.59 crore, and consolidated PAT was INR 7.25 crore. The consolidated EBITDA margin stood at 10.72 percent and PAT margin at 5.32 percent.

The longer trend line in the presentation supports the shift in scale. Consolidated revenue from operations moved from INR 77.35 crore in FY25 to INR 136.07 crore in FY26, while consolidated PAT moved from INR 4.62 crore to INR 7.25 crore over the same period.

Strategic shift: from pigment dispersions to a construction chemicals platform

Ducol positions itself as a pigment dispersions manufacturer with dual expertise in pigments and dispersion technology. FY26 highlights show a deliberate attempt to build an adjacent platform in waterproofing and construction chemicals through acquisitions and partnerships.

The anchor transaction is the acquisition of Bitumag Industries. The investor presentation states a transaction value of INR 39.7 crore for a 100 percent acquisition, effective April 15, 2025. This acquisition is presented as Ducol’s entry into non-pigment dispersions, specifically waterproofing and construction chemicals. It also becomes an operational lever, with a post-acquisition second manufacturing line that doubled capacity.

Bitumag’s performance is disclosed in the presentation. Revenue increased from INR 41.20 crore in FY25 to INR 52.11 crore in FY26, while PAT moved from INR 3.63 crore to INR 3.19 crore. In operational terms, Bitumag’s capacity is stated at 10 million square meters per annum after the second line commissioning. Utilization is described as targeting more than 50 percent. The presentation also notes that 30 to 35 percent capacity is earmarked for Malaysia exports and 20 percent capacity is allocated to the Malaysian market via a distribution partner.

The second acquisition in this new vertical is Xchem Polymer India Pvt. Ltd. The company states that the SPA was signed on March 26, 2026 in Vapi, Gujarat, and that the sector is construction chemicals and industrial adhesives. The structure is phased. Phase 1 is INR 38 crore cash for a 50.67 percent stake. Phase 2 includes INR 30 crore via share swap, plus a balance amount to be retained and paid within 2 years to acquire 100 percent. The presentation also states that around 17.65 lakh Ducol shares were acquired by Xchem promoters via a share swap at INR 170 per share.

Xchem’s disclosed financials show revenue of INR 60.29 crore in FY25 and INR 72.17 crore in FY26 provisional, while PAT is shown at INR 3.37 crore in FY25 and INR 6.93 crore in FY26 provisional. Management commentary indicates that the acquisition is nearing completion and is expected to enhance the product portfolio, market reach, and cross-selling opportunities.

Export partnerships and capacity expansion: building leverage without immediate capex

Beyond acquisitions, Ducol emphasizes partnerships as a means to access markets with lower execution risk. The presentation highlights a partnership ecosystem to expand in Southeast Asia, the Subcontinent, the Middle East, and Africa.

A key named partnership is with Qualibit Chemicals and Industries in Malaysia. The document states that 20 percent of Bitumag capacity is allocated to the Malaysian market via Qualibit, through Polybit, the selling distribution arm. It further states that Polybit has a sourcing relationship with Bitumag for more than 5 years, suggesting that product validation and qualification has already been done.

This matters because it directly ties into the operational objective of improving utilization. The presentation makes the point that Bitumag’s 10 million square meter capacity finds a ready export channel, improving operating leverage without capex.

Separately, the company outlines broader manufacturing capacity expansion plans across its legacy dispersion and masterbatch lines. It states current and planned capacities for wet dispersions, dry dispersions, and masterbatches.

While the presentation does not provide a detailed capex number or commissioning timeline, it makes clear that the growth plan is built around scaling capacity, improving utilization, and expanding international presence.

What management is emphasizing going forward

Management’s commentary is consistent with a transition year: the company is integrating a large acquisition, adding a second one, and absorbing the short-term costs of funding and due diligence. The managing director states that EBITDA margins remained healthy and within the targeted range, while PAT was affected by acquisition-related expenses and finance costs. The commentary also highlights that these costs are transitional and linked to a long-term diversification strategy.

The way ahead section aligns with this framing. The company states its intention to expand beyond pigment dispersions by scaling the non-pigment dispersion and construction chemicals portfolio through acquisitions and partnerships, improve utilization at acquired facilities to drive operating leverage and margin expansion, and accelerate international market expansion via partnerships and alliances.

Balance sheet metrics also show the trade-offs. Working capital days improved to 87 in FY26 from 103 in FY25, while debt to equity increased to 0.44 in FY26 from 0.30 in FY25. The presentation also reports RoCE at 9.25 percent in FY26 and RoE at 7.44 percent.

Takeaways

FY26 is a year where consolidated scale improved materially, driven by the inclusion of Bitumag and a strategic expansion into waterproofing and construction chemicals. At the same time, the documents show that acquisition funding and one-time diligence costs weighed on standalone profitability.

The investment case the company is presenting is centered on integration benefits, higher utilization at acquired facilities, and export-led operating leverage via partnerships like Qualibit. The near-term financial focus is likely to remain on improving margins as acquisition-related debt is repaid, while the strategic focus stays on building a broader specialty and construction chemicals platform.